A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B007 in Subjects With Pemphigus.
Status: Recruiting
Location: See all (12) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with pemphigus.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Subjects who voluntarily participate in this study and sign informed consent form;
• Subjects who meet the clinical manifestations of pemphigus and are clinically diagnosed as prescribed diseases;
• Subjects with first diagnosis or relapse;
• Subjects who have the ability to follow the study protocol as determined by the investigator.
Locations
Other Locations
China
Peking University First Hospital
RECRUITING
Beijing
The Second Xiangya Hospital of Central South University
RECRUITING
Changsha
Chengdu Second People's Hospital
RECRUITING
Chengdu
West China Hospital, Sichuan University
RECRUITING
Chengdu
The First Affiliated Hospital of Chongqing Medical University
RECRUITING
Chongqing
The First Affiliated Hospital of Fujian Medical University
RECRUITING
Fuzhou
Dermatology Hospital of Southern Medical University
RECRUITING
Guangzhou
Guangdong Provincial People's Hospital
RECRUITING
Guangzhou
Shandong First Medical University-Affiliated Skin Hospital
RECRUITING
Jinan
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
RECRUITING
Shanghai
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING
Wuhan
Henan Provincial People's Hospital
RECRUITING
Zhengzhou
Contact Information
Primary
Hang Li
bdyyec@163.com
0086-010-66119025
Time Frame
Start Date: 2024-07-12
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 132
Treatments
Experimental: B007
Related Therapeutic Areas
Sponsors
Leads: Shanghai Jiaolian Drug Research and Development Co., Ltd
Collaborators: Shanghai Pharmaceuticals Holding Co., Ltd